

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.64485318 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.64485318 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.32939286 |
| 4 | skeletal muscle contraction (GO:0003009) | 7.44787129 |
| 5 | actin-mediated cell contraction (GO:0070252) | 6.95265335 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 6.61100698 |
| 7 | dopamine biosynthetic process (GO:0042416) | 6.55237776 |
| 8 | dopamine transport (GO:0015872) | 6.11379521 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 5.93528708 |
| 10 | creatine metabolic process (GO:0006600) | 5.90568482 |
| 11 | mating behavior (GO:0007617) | 5.75659724 |
| 12 | striated muscle contraction (GO:0006941) | 5.71165163 |
| 13 | alkaloid metabolic process (GO:0009820) | 5.58665456 |
| 14 | catecholamine transport (GO:0051937) | 5.44589272 |
| 15 | phenol-containing compound catabolic process (GO:0019336) | 5.38234394 |
| 16 | actin filament-based movement (GO:0030048) | 5.19478214 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.07815842 |
| 18 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.07458888 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.04999711 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.04482621 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 4.99236559 |
| 22 | skeletal muscle fiber development (GO:0048741) | 4.86889539 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.83009482 |
| 24 | vocalization behavior (GO:0071625) | 4.80849327 |
| 25 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.75631677 |
| 26 | myofibril assembly (GO:0030239) | 4.75155961 |
| 27 | catecholamine biosynthetic process (GO:0042423) | 4.62892477 |
| 28 | catechol-containing compound biosynthetic process (GO:0009713) | 4.62892477 |
| 29 | response to insecticide (GO:0017085) | 4.62563120 |
| 30 | sarcomere organization (GO:0045214) | 4.59358472 |
| 31 | response to inactivity (GO:0014854) | 4.59071400 |
| 32 | response to muscle activity (GO:0014850) | 4.58847841 |
| 33 | NADH metabolic process (GO:0006734) | 4.56220312 |
| 34 | neurotransmitter secretion (GO:0007269) | 4.51933587 |
| 35 | synaptic transmission, dopaminergic (GO:0001963) | 4.49208701 |
| 36 | cardiac muscle contraction (GO:0060048) | 4.44183256 |
| 37 | locomotory exploration behavior (GO:0035641) | 4.25404288 |
| 38 | glutamate secretion (GO:0014047) | 4.24995116 |
| 39 | myotube cell development (GO:0014904) | 4.21908605 |
| 40 | proline transport (GO:0015824) | 4.17979091 |
| 41 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.17172645 |
| 42 | muscle contraction (GO:0006936) | 4.15230526 |
| 43 | synaptic vesicle maturation (GO:0016188) | 4.14516620 |
| 44 | plasma membrane repair (GO:0001778) | 4.08764676 |
| 45 | skeletal muscle adaptation (GO:0043501) | 4.08700970 |
| 46 | neurotransmitter transport (GO:0006836) | 4.08230698 |
| 47 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.08096665 |
| 48 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.01073028 |
| 49 | dopamine metabolic process (GO:0042417) | 3.97298771 |
| 50 | glycogen catabolic process (GO:0005980) | 3.93759697 |
| 51 | * regulation of neurotransmitter levels (GO:0001505) | 3.89865523 |
| 52 | regulation of dopamine metabolic process (GO:0042053) | 3.89574269 |
| 53 | regulation of catecholamine metabolic process (GO:0042069) | 3.89574269 |
| 54 | regulation of cell communication by electrical coupling (GO:0010649) | 3.89574061 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85368347 |
| 56 | prepulse inhibition (GO:0060134) | 3.84667737 |
| 57 | * neurotransmitter biosynthetic process (GO:0042136) | 3.83104117 |
| 58 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.83023335 |
| 59 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.79679827 |
| 60 | behavioral response to ethanol (GO:0048149) | 3.79037244 |
| 61 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.78412427 |
| 62 | glucan catabolic process (GO:0009251) | 3.77132583 |
| 63 | negative regulation of neurotransmitter transport (GO:0051589) | 3.76122739 |
| 64 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.76090421 |
| 65 | regulation of protein kinase A signaling (GO:0010738) | 3.74867623 |
| 66 | response to amphetamine (GO:0001975) | 3.73625331 |
| 67 | gluconeogenesis (GO:0006094) | 3.73041744 |
| 68 | exploration behavior (GO:0035640) | 3.71917081 |
| 69 | muscle system process (GO:0003012) | 3.68142490 |
| 70 | neuron recognition (GO:0008038) | 3.66872084 |
| 71 | regulation of vesicle fusion (GO:0031338) | 3.63692556 |
| 72 | response to histamine (GO:0034776) | 3.61536903 |
| 73 | protein localization to synapse (GO:0035418) | 3.61156264 |
| 74 | muscle fiber development (GO:0048747) | 3.59828495 |
| 75 | positive regulation of synapse maturation (GO:0090129) | 3.54676290 |
| 76 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.54325559 |
| 77 | cardiac myofibril assembly (GO:0055003) | 3.53979361 |
| 78 | fructose metabolic process (GO:0006000) | 3.50027776 |
| 79 | behavioral response to cocaine (GO:0048148) | 3.49450732 |
| 80 | actomyosin structure organization (GO:0031032) | 3.48728432 |
| 81 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48474441 |
| 82 | cellular polysaccharide catabolic process (GO:0044247) | 3.48150052 |
| 83 | response to cocaine (GO:0042220) | 3.47015815 |
| 84 | behavioral response to nicotine (GO:0035095) | 3.43643985 |
| 85 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.43059713 |
| 86 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.43059713 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 3.41814319 |
| 88 | * neurotransmitter catabolic process (GO:0042135) | 3.39451932 |
| 89 | regulation of actin filament-based movement (GO:1903115) | 3.39387165 |
| 90 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.34039905 |
| 91 | hexose biosynthetic process (GO:0019319) | 3.33916093 |
| 92 | striatum development (GO:0021756) | 3.33149505 |
| 93 | * neurotransmitter metabolic process (GO:0042133) | 3.33091329 |
| 94 | neuron-neuron synaptic transmission (GO:0007270) | 3.32924211 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 3.32544128 |
| 96 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.30912901 |
| 97 | striated muscle adaptation (GO:0014888) | 3.29617642 |
| 98 | positive regulation of synapse assembly (GO:0051965) | 3.29348225 |
| 99 | regulation of synaptic vesicle transport (GO:1902803) | 3.28891649 |
| 100 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.27850483 |
| 101 | toxin metabolic process (GO:0009404) | 3.27038300 |
| 102 | regulation of synapse structural plasticity (GO:0051823) | 3.26815456 |
| 103 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.26692716 |
| 104 | glucan biosynthetic process (GO:0009250) | 3.26584968 |
| 105 | glycogen biosynthetic process (GO:0005978) | 3.26584968 |
| 106 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.26492237 |
| 107 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.26492237 |
| 108 | skeletal muscle tissue development (GO:0007519) | 3.24654550 |
| 109 | social behavior (GO:0035176) | 3.23023054 |
| 110 | intraspecies interaction between organisms (GO:0051703) | 3.23023054 |
| 111 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.22685925 |
| 112 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.22685925 |
| 113 | monoamine transport (GO:0015844) | 3.21822220 |
| 114 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.21724526 |
| 115 | neuronal action potential propagation (GO:0019227) | 3.21484225 |
| 116 | multi-organism reproductive behavior (GO:0044705) | 3.21123719 |
| 117 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.20891543 |
| 118 | ATP synthesis coupled proton transport (GO:0015986) | 3.20429695 |
| 119 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.20429695 |
| 120 | regulation of glutamate secretion (GO:0014048) | 3.19162615 |
| 121 | transmission of nerve impulse (GO:0019226) | 3.18203648 |
| 122 | muscle cell cellular homeostasis (GO:0046716) | 3.17022314 |
| 123 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.16263055 |
| 124 | negative regulation of microtubule polymerization (GO:0031115) | 3.15887125 |
| 125 | establishment of synaptic vesicle localization (GO:0097480) | 3.15861684 |
| 126 | synaptic vesicle transport (GO:0048489) | 3.15861684 |
| 127 | regulation of dopamine secretion (GO:0014059) | 3.15443665 |
| 128 | cerebellar Purkinje cell layer development (GO:0021680) | 3.15178686 |
| 129 | oxygen transport (GO:0015671) | 3.13898090 |
| 130 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.13225091 |
| 131 | cardiac muscle hypertrophy (GO:0003300) | 3.12586910 |
| 132 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.12544054 |
| 133 | mitochondrion transport along microtubule (GO:0047497) | 3.12544054 |
| 134 | layer formation in cerebral cortex (GO:0021819) | 3.12038934 |
| 135 | auditory behavior (GO:0031223) | 3.10099158 |
| 136 | polysaccharide catabolic process (GO:0000272) | 3.09250463 |
| 137 | reproductive behavior (GO:0019098) | 3.08259739 |
| 138 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.08206579 |
| 139 | establishment of mitochondrion localization (GO:0051654) | 3.08199576 |
| 140 | postsynaptic membrane organization (GO:0001941) | 3.07104298 |
| 141 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.06486733 |
| 142 | gamma-aminobutyric acid transport (GO:0015812) | 3.06080634 |
| 143 | activation of protein kinase A activity (GO:0034199) | 3.05208035 |
| 144 | axonal fasciculation (GO:0007413) | 3.05151445 |
| 145 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.05087817 |
| 146 | neuromuscular synaptic transmission (GO:0007274) | 3.03578601 |
| 147 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.03460156 |
| 148 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.02934189 |
| 149 | electron transport chain (GO:0022900) | 3.02525994 |
| 150 | respiratory electron transport chain (GO:0022904) | 3.02411794 |
| 151 | cellular response to nicotine (GO:0071316) | 3.02024846 |
| 152 | cellular potassium ion homeostasis (GO:0030007) | 3.00296669 |
| 153 | glutamate receptor signaling pathway (GO:0007215) | 3.00050922 |
| 154 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99216626 |
| 155 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.99017595 |
| 156 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.99017595 |
| 157 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.98992221 |
| 158 | regulation of neurotransmitter transport (GO:0051588) | 2.98634182 |
| 159 | phenol-containing compound biosynthetic process (GO:0046189) | 2.97488689 |
| 160 | striated muscle hypertrophy (GO:0014897) | 2.96959694 |
| 161 | respiratory system process (GO:0003016) | 2.96907647 |
| 162 | transferrin transport (GO:0033572) | 2.96237222 |
| 163 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.95117282 |
| 164 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.92715383 |
| 165 | positive regulation of myotube differentiation (GO:0010831) | 2.92703127 |
| 166 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92672447 |
| 167 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.92488540 |
| 168 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.88704623 |
| 169 | myoblast fusion (GO:0007520) | 2.86344385 |
| 170 | monosaccharide biosynthetic process (GO:0046364) | 2.86274997 |
| 171 | striated muscle atrophy (GO:0014891) | 2.86008926 |
| 172 | regulation of striated muscle contraction (GO:0006942) | 2.85760128 |
| 173 | regulation of membrane repolarization (GO:0060306) | 2.84241216 |
| 174 | membrane depolarization during action potential (GO:0086010) | 2.84217510 |
| 175 | sodium ion export (GO:0071436) | 2.84015915 |
| 176 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.83213320 |
| 177 | regulation of synapse maturation (GO:0090128) | 2.83194769 |
| 178 | * muscle organ development (GO:0007517) | 2.76796868 |
| 179 | oxaloacetate metabolic process (GO:0006107) | 2.75689153 |
| 180 | * muscle structure development (GO:0061061) | 2.75015171 |
| 181 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.74994078 |
| 182 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.71979857 |
| 183 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.71476596 |
| 184 | glycolytic process (GO:0006096) | 2.71369928 |
| 185 | muscle adaptation (GO:0043500) | 2.69951623 |
| 186 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.69703030 |
| 187 | glycogen metabolic process (GO:0005977) | 2.66692636 |
| 188 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.65860724 |
| 189 | glucan metabolic process (GO:0044042) | 2.63545168 |
| 190 | cellular glucan metabolic process (GO:0006073) | 2.63545168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.94698127 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33957959 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.27129653 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.17131087 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09604799 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.03917884 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.03195512 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.88151110 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69802284 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69699663 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67658932 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64393829 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64393829 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.62652711 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.61859044 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.61293969 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.61208481 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55384271 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55365689 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53691122 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53632324 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50387320 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29889891 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29366518 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.25032523 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22694670 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.18785050 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.15808116 |
| 29 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.13842320 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11615387 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11493374 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.06575467 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.04316883 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.00006325 |
| 35 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.98947515 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94053645 |
| 37 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.92231257 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89041338 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85449457 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82862954 |
| 41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.82793763 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80697458 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.77797542 |
| 44 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.72827745 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.71154445 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68925860 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67643325 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67368161 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62677967 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60241236 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57983188 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56212569 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54921450 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.53086085 |
| 55 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52842593 |
| 56 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49527437 |
| 57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49523160 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47690558 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47338880 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45175419 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.45077464 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44535771 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44163430 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43785214 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43143584 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42330133 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41493772 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41003942 |
| 69 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.40889075 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40778710 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40272969 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39551398 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38341362 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36922057 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34964348 |
| 76 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32618835 |
| 77 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32523417 |
| 78 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.31865152 |
| 79 | SA1_27219007_Chip-Seq_Bcells_Human | 1.31782864 |
| 80 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29647650 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29522147 |
| 82 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29433306 |
| 83 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29230977 |
| 84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28402235 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27979178 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26849432 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26599817 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26595549 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25755520 |
| 90 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25311082 |
| 91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.25131555 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24838645 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24235981 |
| 94 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23019444 |
| 95 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23019444 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22914871 |
| 97 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21960901 |
| 98 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21800650 |
| 99 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21783730 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20070352 |
| 101 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.19413698 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19331527 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18700510 |
| 104 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17755087 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15866007 |
| 106 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15207903 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.14237048 |
| 108 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13696700 |
| 109 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13558377 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 1.12903931 |
| 111 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.12784526 |
| 112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11699632 |
| 113 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11581191 |
| 114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11409185 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09666370 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08723363 |
| 117 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.08663651 |
| 118 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08367490 |
| 119 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07250649 |
| 120 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06297263 |
| 121 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.05516897 |
| 122 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05408679 |
| 123 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05388170 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05386485 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05130143 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04031654 |
| 127 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.03072952 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02277242 |
| 129 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02096665 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01094203 |
| 131 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.00845889 |
| 132 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00570407 |
| 133 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98320446 |
| 134 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98217867 |
| 135 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.97875720 |
| 136 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96383851 |
| 137 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96327649 |
| 138 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95966819 |
| 139 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95620678 |
| 140 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94453297 |
| 141 | AR_19668381_ChIP-Seq_PC3_Human | 0.94289857 |
| 142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92892894 |
| 143 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92151275 |
| 144 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91748943 |
| 145 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90968061 |
| 146 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90719883 |
| 147 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.90690346 |
| 148 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.90558436 |
| 149 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89184873 |
| 150 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86251592 |
| 151 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85974485 |
| 152 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84947850 |
| 153 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.84783473 |
| 154 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84657426 |
| 155 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84498956 |
| 156 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84131479 |
| 157 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83724350 |
| 158 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83724350 |
| 159 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.82921328 |
| 160 | KDM2B_26808549_Chip-Seq_REH_Human | 0.82442455 |
| 161 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.81792825 |
| 162 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81776291 |
| 163 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80723961 |
| 164 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80414681 |
| 165 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79793338 |
| 166 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79051503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.13949881 |
| 2 | MP0003880_abnormal_central_pattern | 5.04083625 |
| 3 | MP0000749_muscle_degeneration | 4.82846425 |
| 4 | MP0002822_catalepsy | 4.62984464 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 4.03776764 |
| 6 | MP0001905_abnormal_dopamine_level | 3.66176378 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.50453659 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.22965811 |
| 9 | MP0009745_abnormal_behavioral_response | 3.19968905 |
| 10 | MP0009046_muscle_twitch | 3.16375149 |
| 11 | * MP0006276_abnormal_autonomic_nervous | 3.03288848 |
| 12 | MP0002106_abnormal_muscle_physiology | 3.01828961 |
| 13 | * MP0002064_seizures | 2.91970875 |
| 14 | MP0005451_abnormal_body_composition | 2.90525145 |
| 15 | * MP0000747_muscle_weakness | 2.88200150 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.86739431 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.85109920 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.84758433 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.76521585 |
| 20 | MP0003122_maternal_imprinting | 2.72256279 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.69069747 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.62834063 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.62763173 |
| 24 | MP0002063_abnormal_learning/memory/cond | 2.62599122 |
| 25 | MP0004130_abnormal_muscle_cell | 2.56016505 |
| 26 | MP0004147_increased_porphyrin_level | 2.51104760 |
| 27 | MP0005369_muscle_phenotype | 2.49219121 |
| 28 | MP0002733_abnormal_thermal_nociception | 2.48623778 |
| 29 | MP0000750_abnormal_muscle_regeneration | 2.46723582 |
| 30 | MP0002734_abnormal_mechanical_nocicepti | 2.45612153 |
| 31 | MP0004270_analgesia | 2.45536594 |
| 32 | MP0002269_muscular_atrophy | 2.36504812 |
| 33 | MP0002272_abnormal_nervous_system | 2.34159112 |
| 34 | * MP0001529_abnormal_vocalization | 2.31755786 |
| 35 | MP0004233_abnormal_muscle_weight | 2.30858075 |
| 36 | MP0005620_abnormal_muscle_contractility | 2.27082072 |
| 37 | MP0002735_abnormal_chemical_nociception | 2.25627140 |
| 38 | MP0001970_abnormal_pain_threshold | 2.19678557 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 2.18661089 |
| 40 | MP0001486_abnormal_startle_reflex | 2.17066579 |
| 41 | * MP0002332_abnormal_exercise_endurance | 2.04517692 |
| 42 | MP0004084_abnormal_cardiac_muscle | 2.03954990 |
| 43 | MP0005330_cardiomyopathy | 2.02700342 |
| 44 | MP0002736_abnormal_nociception_after | 2.00998390 |
| 45 | * MP0005386_behavior/neurological_phenoty | 1.92579433 |
| 46 | * MP0004924_abnormal_behavior | 1.92579433 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.88842435 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.85057673 |
| 49 | * MP0002067_abnormal_sensory_capabilities | 1.85021379 |
| 50 | MP0002184_abnormal_innervation | 1.84319683 |
| 51 | MP0004142_abnormal_muscle_tone | 1.78666876 |
| 52 | MP0001188_hyperpigmentation | 1.74137177 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.72151411 |
| 54 | MP0002972_abnormal_cardiac_muscle | 1.65017336 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.61619333 |
| 56 | MP0000733_abnormal_muscle_development | 1.58133392 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.51800781 |
| 58 | MP0004510_myositis | 1.51567278 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.49941704 |
| 60 | MP0003329_amyloid_beta_deposits | 1.49468412 |
| 61 | MP0004858_abnormal_nervous_system | 1.48164875 |
| 62 | MP0008569_lethality_at_weaning | 1.47844376 |
| 63 | MP0000778_abnormal_nervous_system | 1.44015511 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.43387319 |
| 65 | * MP0008872_abnormal_physiological_respon | 1.41090536 |
| 66 | MP0000751_myopathy | 1.38840178 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.38586152 |
| 68 | * MP0002066_abnormal_motor_capabilities/c | 1.34457692 |
| 69 | MP0000538_abnormal_urinary_bladder | 1.32246384 |
| 70 | MP0004811_abnormal_neuron_physiology | 1.30944120 |
| 71 | MP0001984_abnormal_olfaction | 1.30905309 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.30217981 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.29867733 |
| 74 | MP0000955_abnormal_spinal_cord | 1.28550029 |
| 75 | MP0002971_abnormal_brown_adipose | 1.28252108 |
| 76 | MP0009840_abnormal_foam_cell | 1.26356853 |
| 77 | MP0002108_abnormal_muscle_morphology | 1.23810176 |
| 78 | MP0004484_altered_response_of | 1.22629262 |
| 79 | MP0002882_abnormal_neuron_morphology | 1.21915012 |
| 80 | MP0005409_darkened_coat_color | 1.20013364 |
| 81 | * MP0005535_abnormal_body_temperature | 1.19369862 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15244483 |
| 83 | MP0005083_abnormal_biliary_tract | 1.14394231 |
| 84 | MP0003879_abnormal_hair_cell | 1.12446276 |
| 85 | MP0010630_abnormal_cardiac_muscle | 1.12195677 |
| 86 | MP0002254_reproductive_system_inflammat | 1.10492307 |
| 87 | MP0006138_congestive_heart_failure | 1.10013879 |
| 88 | MP0002751_abnormal_autonomic_nervous | 1.09926946 |
| 89 | MP0001664_abnormal_digestion | 1.09506535 |
| 90 | MP0002090_abnormal_vision | 1.04875093 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 1.00977759 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.99510884 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.99255762 |
| 94 | MP0004742_abnormal_vestibular_system | 0.97453733 |
| 95 | MP0003633_abnormal_nervous_system | 0.96431731 |
| 96 | MP0001544_abnormal_cardiovascular_syste | 0.95852389 |
| 97 | MP0005385_cardiovascular_system_phenoty | 0.95852389 |
| 98 | MP0003631_nervous_system_phenotype | 0.95227595 |
| 99 | MP0002229_neurodegeneration | 0.94475937 |
| 100 | MP0008874_decreased_physiological_sensi | 0.94470619 |
| 101 | * MP0005266_abnormal_metabolism | 0.94189797 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.93657940 |
| 103 | MP0005551_abnormal_eye_electrophysiolog | 0.90789937 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.90192536 |
| 105 | MP0005670_abnormal_white_adipose | 0.89391862 |
| 106 | MP0002127_abnormal_cardiovascular_syste | 0.87512240 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.87322153 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.87272090 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.85590433 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.85384136 |
| 111 | MP0004145_abnormal_muscle_electrophysio | 0.84942269 |
| 112 | * MP0002152_abnormal_brain_morphology | 0.84737621 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.82868734 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.81453355 |
| 115 | MP0004085_abnormal_heartbeat | 0.78158221 |
| 116 | MP0005394_taste/olfaction_phenotype | 0.78129981 |
| 117 | MP0005499_abnormal_olfactory_system | 0.78129981 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.77679022 |
| 119 | MP0003632_abnormal_nervous_system | 0.77263134 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.76903888 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.75933941 |
| 122 | MP0002163_abnormal_gland_morphology | 0.75562233 |
| 123 | MP0009780_abnormal_chondrocyte_physiolo | 0.74465947 |
| 124 | MP0009379_abnormal_foot_pigmentation | 0.73084923 |
| 125 | MP0003121_genomic_imprinting | 0.70115884 |
| 126 | MP0003787_abnormal_imprinting | 0.69044467 |
| 127 | MP0003634_abnormal_glial_cell | 0.64328411 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.64213724 |
| 129 | MP0001177_atelectasis | 0.63779553 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.63279770 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.63050645 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62935697 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.62827879 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.62463282 |
| 135 | MP0004215_abnormal_myocardial_fiber | 0.62151635 |
| 136 | MP0000604_amyloidosis | 0.61860095 |
| 137 | * MP0001943_abnormal_respiration | 0.60985692 |
| 138 | MP0008260_abnormal_autophagy | 0.60183555 |
| 139 | MP0003123_paternal_imprinting | 0.58583314 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.58009081 |
| 141 | MP0005310_abnormal_salivary_gland | 0.56176445 |
| 142 | MP0008961_abnormal_basal_metabolism | 0.55885486 |
| 143 | MP0003283_abnormal_digestive_organ | 0.54341439 |
| 144 | MP0003045_fibrosis | 0.54238710 |
| 145 | MP0003690_abnormal_glial_cell | 0.53814363 |
| 146 | MP0003948_abnormal_gas_homeostasis | 0.53450881 |
| 147 | MP0004885_abnormal_endolymph | 0.50949627 |
| 148 | MP0001346_abnormal_lacrimal_gland | 0.49135583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.35258818 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 9.33850895 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.05007137 |
| 4 | Limb dystonia (HP:0002451) | 8.22571737 |
| 5 | Exercise-induced myalgia (HP:0003738) | 7.47261806 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 7.04078840 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 6.61103893 |
| 8 | Focal motor seizures (HP:0011153) | 5.95702334 |
| 9 | Myopathic facies (HP:0002058) | 5.77331445 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.54131432 |
| 11 | Distal arthrogryposis (HP:0005684) | 5.45854042 |
| 12 | Myokymia (HP:0002411) | 5.34594578 |
| 13 | Visual hallucinations (HP:0002367) | 5.32915709 |
| 14 | Hypothermia (HP:0002045) | 5.24789595 |
| 15 | Calf muscle hypertrophy (HP:0008981) | 4.96717856 |
| 16 | Focal seizures (HP:0007359) | 4.89656647 |
| 17 | Pheochromocytoma (HP:0002666) | 4.88489540 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.62500839 |
| 19 | Round ear (HP:0100830) | 4.59576369 |
| 20 | Myoglobinuria (HP:0002913) | 4.49629177 |
| 21 | Neuroendocrine neoplasm (HP:0100634) | 4.40726874 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.40661333 |
| 23 | Muscle fiber splitting (HP:0003555) | 4.31517426 |
| 24 | Ulnar deviation of the wrist (HP:0003049) | 4.29794887 |
| 25 | Failure to thrive in infancy (HP:0001531) | 4.29431049 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.21339098 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 4.08255638 |
| 28 | Atonic seizures (HP:0010819) | 3.98340724 |
| 29 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.94413022 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.90418856 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 3.86575464 |
| 32 | Absence seizures (HP:0002121) | 3.85512676 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 3.83350018 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.82491805 |
| 35 | Difficulty running (HP:0009046) | 3.81627091 |
| 36 | Calcaneovalgus deformity (HP:0001848) | 3.74923454 |
| 37 | Neck muscle weakness (HP:0000467) | 3.73384729 |
| 38 | Febrile seizures (HP:0002373) | 3.55881094 |
| 39 | Hypoventilation (HP:0002791) | 3.54283852 |
| 40 | Muscle stiffness (HP:0003552) | 3.53107996 |
| 41 | Increased connective tissue (HP:0009025) | 3.45429679 |
| 42 | Dialeptic seizures (HP:0011146) | 3.43230994 |
| 43 | Subaortic stenosis (HP:0001682) | 3.38904596 |
| 44 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.38904596 |
| 45 | Hypercortisolism (HP:0001578) | 3.38384109 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 3.32126266 |
| 47 | Deformed tarsal bones (HP:0008119) | 3.30046171 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 3.29476407 |
| 49 | Frequent falls (HP:0002359) | 3.28554930 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 3.27264341 |
| 51 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.20259155 |
| 52 | Absent phalangeal crease (HP:0006109) | 3.14899577 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 3.14382356 |
| 54 | Abnormal pupillary function (HP:0007686) | 3.14156990 |
| 55 | Anxiety (HP:0000739) | 3.14005395 |
| 56 | Cerebral hemorrhage (HP:0001342) | 3.11821580 |
| 57 | EMG: neuropathic changes (HP:0003445) | 3.11053271 |
| 58 | Epileptic encephalopathy (HP:0200134) | 3.10920387 |
| 59 | Progressive inability to walk (HP:0002505) | 3.10219409 |
| 60 | Sudden death (HP:0001699) | 3.10024120 |
| 61 | Distal lower limb amyotrophy (HP:0008944) | 3.04714810 |
| 62 | Potter facies (HP:0002009) | 2.98288309 |
| 63 | Facial shape deformation (HP:0011334) | 2.98288309 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.97671243 |
| 65 | Malignant hyperthermia (HP:0002047) | 2.97577893 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.97152616 |
| 67 | Asymmetric septal hypertrophy (HP:0001670) | 2.96722426 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.95224094 |
| 69 | Progressive macrocephaly (HP:0004481) | 2.93431969 |
| 70 | Polyphagia (HP:0002591) | 2.90887744 |
| 71 | Hypokinesia (HP:0002375) | 2.82139806 |
| 72 | Lower limb amyotrophy (HP:0007210) | 2.74827526 |
| 73 | Depression (HP:0000716) | 2.73131380 |
| 74 | Amblyopia (HP:0000646) | 2.69872412 |
| 75 | Agitation (HP:0000713) | 2.69217723 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.67283276 |
| 77 | Abnormal eating behavior (HP:0100738) | 2.63636713 |
| 78 | Bundle branch block (HP:0011710) | 2.63002201 |
| 79 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.61665424 |
| 80 | Areflexia of lower limbs (HP:0002522) | 2.50940682 |
| 81 | Abnormal finger flexion creases (HP:0006143) | 2.50103971 |
| 82 | Generalized muscle weakness (HP:0003324) | 2.49957463 |
| 83 | Abnormality of the foot musculature (HP:0001436) | 2.47652934 |
| 84 | Bulbar palsy (HP:0001283) | 2.46716326 |
| 85 | Action tremor (HP:0002345) | 2.44113276 |
| 86 | Difficulty climbing stairs (HP:0003551) | 2.44093993 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 2.43919963 |
| 88 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.40851869 |
| 89 | Acute encephalopathy (HP:0006846) | 2.40625898 |
| 90 | Psychosis (HP:0000709) | 2.39354630 |
| 91 | Abnormal hair whorl (HP:0010721) | 2.38116121 |
| 92 | Truncal ataxia (HP:0002078) | 2.38041789 |
| 93 | Diminished movement (HP:0002374) | 2.37567829 |
| 94 | Ankle clonus (HP:0011448) | 2.36198785 |
| 95 | Genital tract atresia (HP:0001827) | 2.35361334 |
| 96 | Rigidity (HP:0002063) | 2.35198571 |
| 97 | Bradykinesia (HP:0002067) | 2.34048034 |
| 98 | Mutism (HP:0002300) | 2.31396837 |
| 99 | Broad-based gait (HP:0002136) | 2.31057208 |
| 100 | Increased CSF lactate (HP:0002490) | 2.27439242 |
| 101 | Vaginal atresia (HP:0000148) | 2.25159619 |
| 102 | Poor suck (HP:0002033) | 2.25118224 |
| 103 | Abnormality of the calcaneus (HP:0008364) | 2.24664080 |
| 104 | Limb-girdle muscle atrophy (HP:0003797) | 2.23157155 |
| 105 | Postural tremor (HP:0002174) | 2.18660659 |
| 106 | Gowers sign (HP:0003391) | 2.18627662 |
| 107 | Delayed gross motor development (HP:0002194) | 2.17682931 |
| 108 | Hepatocellular necrosis (HP:0001404) | 2.16742065 |
| 109 | Weak cry (HP:0001612) | 2.16475145 |
| 110 | Delusions (HP:0000746) | 2.15105123 |
| 111 | Akinesia (HP:0002304) | 2.14762576 |
| 112 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.13185147 |
| 113 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.12882597 |
| 114 | Dysmetria (HP:0001310) | 2.11432487 |
| 115 | Cholelithiasis (HP:0001081) | 2.09988067 |
| 116 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.09565748 |
| 117 | Orthostatic hypotension (HP:0001278) | 2.08348363 |
| 118 | Hemiparesis (HP:0001269) | 2.07703142 |
| 119 | Termporal pattern (HP:0011008) | 2.06992269 |
| 120 | Insidious onset (HP:0003587) | 2.06992269 |
| 121 | Papilledema (HP:0001085) | 2.06491354 |
| 122 | Abnormality of the corticospinal tract (HP:0002492) | 2.05497787 |
| 123 | Scapular winging (HP:0003691) | 2.04981617 |
| 124 | Exotropia (HP:0000577) | 2.04429111 |
| 125 | Slender build (HP:0001533) | 2.03647608 |
| 126 | Myotonia (HP:0002486) | 2.03187817 |
| 127 | Reticulocytosis (HP:0001923) | 2.02518955 |
| 128 | Paralysis (HP:0003470) | 2.00501570 |
| 129 | Fatigable weakness (HP:0003473) | 2.00042809 |
| 130 | Abnormality of the neuromuscular junction (HP:0003398) | 2.00042809 |
| 131 | Abnormality of binocular vision (HP:0011514) | 1.99832198 |
| 132 | Diplopia (HP:0000651) | 1.99832198 |
| 133 | Abnormality of the parathyroid morphology (HP:0011766) | 1.98514869 |
| 134 | Hyperthyroidism (HP:0000836) | 1.98442715 |
| 135 | Dilated cardiomyopathy (HP:0001644) | 1.98259101 |
| 136 | Esotropia (HP:0000565) | 1.97120223 |
| 137 | Muscular hypotonia of the trunk (HP:0008936) | 1.95581093 |
| 138 | Torticollis (HP:0000473) | 1.94425667 |
| 139 | Gait imbalance (HP:0002141) | 1.94341312 |
| 140 | Optic disc pallor (HP:0000543) | 1.93914141 |
| 141 | Fetal akinesia sequence (HP:0001989) | 1.93552336 |
| 142 | Hyperkalemia (HP:0002153) | 1.93146731 |
| 143 | Abnormal ciliary motility (HP:0012262) | 1.91858899 |
| 144 | Poor eye contact (HP:0000817) | 1.91598490 |
| 145 | Spinal rigidity (HP:0003306) | 1.91467745 |
| 146 | Emotional lability (HP:0000712) | 1.90560005 |
| 147 | Heart block (HP:0012722) | 1.90490309 |
| 148 | Dysdiadochokinesis (HP:0002075) | 1.89886380 |
| 149 | Ventricular tachycardia (HP:0004756) | 1.89303768 |
| 150 | Spastic gait (HP:0002064) | 1.89242388 |
| 151 | Rapidly progressive (HP:0003678) | 1.88907468 |
| 152 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.88246699 |
| 153 | Hyperparathyroidism (HP:0000843) | 1.88012877 |
| 154 | Waddling gait (HP:0002515) | 1.86646657 |
| 155 | Narrow nasal bridge (HP:0000446) | 1.86600466 |
| 156 | Oligomenorrhea (HP:0000876) | 1.86106219 |
| 157 | Abnormal gallbladder morphology (HP:0012437) | 1.85991421 |
| 158 | Increased hepatocellular lipid droplets (HP:0006565) | 1.85328176 |
| 159 | Abnormal social behavior (HP:0012433) | 1.85191512 |
| 160 | Impaired social interactions (HP:0000735) | 1.85191512 |
| 161 | Cholecystitis (HP:0001082) | 1.84819736 |
| 162 | Abnormal gallbladder physiology (HP:0012438) | 1.84819736 |
| 163 | Rimmed vacuoles (HP:0003805) | 1.84464589 |
| 164 | Urinary urgency (HP:0000012) | 1.84060844 |
| 165 | Focal dystonia (HP:0004373) | 1.83418219 |
| 166 | EEG with generalized epileptiform discharges (HP:0011198) | 1.82712227 |
| 167 | Abnormal atrioventricular conduction (HP:0005150) | 1.81881519 |
| 168 | Hip contracture (HP:0003273) | 1.79438104 |
| 169 | Shoulder girdle muscle weakness (HP:0003547) | 1.78263928 |
| 170 | Proximal amyotrophy (HP:0007126) | 1.76077925 |
| 171 | Muscular dystrophy (HP:0003560) | 1.74723403 |
| 172 | Progressive muscle weakness (HP:0003323) | 1.71829012 |
| 173 | Diaphragmatic weakness (HP:0009113) | 1.71588246 |
| 174 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.71458381 |
| 175 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.71458381 |
| 176 | Metatarsus adductus (HP:0001840) | 1.70471137 |
| 177 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65852078 |
| 178 | Steppage gait (HP:0003376) | 1.65246990 |
| 179 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.64069786 |
| 180 | Pelvic girdle muscle weakness (HP:0003749) | 1.63961261 |
| 181 | Achilles tendon contracture (HP:0001771) | 1.63492703 |
| 182 | Lipoatrophy (HP:0100578) | 1.62846796 |
| 183 | Poikilocytosis (HP:0004447) | 1.62763652 |
| 184 | Limb-girdle muscle weakness (HP:0003325) | 1.62402143 |
| 185 | Cerebral palsy (HP:0100021) | 1.62358433 |
| 186 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.58879232 |
| 187 | Popliteal pterygium (HP:0009756) | 1.58861690 |
| 188 | Long clavicles (HP:0000890) | 1.57692460 |
| 189 | Nonprogressive disorder (HP:0003680) | 1.56919078 |
| 190 | Stridor (HP:0010307) | 1.56425549 |
| 191 | Ragged-red muscle fibers (HP:0003200) | 1.55314532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.74291604 |
| 2 | TTN | 4.50612934 |
| 3 | MAP3K12 | 3.94388784 |
| 4 | MAPKAPK5 | 3.60951320 |
| 5 | PNCK | 3.51118295 |
| 6 | MAP3K9 | 3.43537810 |
| 7 | NTRK3 | 3.35460006 |
| 8 | MAP3K4 | 3.02583581 |
| 9 | NTRK1 | 3.01538340 |
| 10 | ARAF | 2.84761412 |
| 11 | GRK5 | 2.55343687 |
| 12 | MINK1 | 2.46425268 |
| 13 | MAP2K4 | 2.45564415 |
| 14 | MAP2K7 | 2.32855096 |
| 15 | MARK1 | 2.29647133 |
| 16 | GRK7 | 2.16032473 |
| 17 | NTRK2 | 2.06129781 |
| 18 | MAPK12 | 2.01625776 |
| 19 | EPHA4 | 1.93329917 |
| 20 | CSNK1G2 | 1.89974481 |
| 21 | CSNK1G3 | 1.88032238 |
| 22 | PINK1 | 1.75977374 |
| 23 | CASK | 1.72296093 |
| 24 | KSR2 | 1.58003432 |
| 25 | MAP2K3 | 1.57565182 |
| 26 | MAP3K13 | 1.54627543 |
| 27 | NME1 | 1.54479836 |
| 28 | RIPK1 | 1.50831622 |
| 29 | PIK3CG | 1.43090698 |
| 30 | PLK2 | 1.34975386 |
| 31 | CDK5 | 1.34635862 |
| 32 | ADRBK2 | 1.31504753 |
| 33 | CAMK2A | 1.29066313 |
| 34 | MAP3K7 | 1.25025362 |
| 35 | CSNK1G1 | 1.24438957 |
| 36 | PRPF4B | 1.23869846 |
| 37 | CAMK2B | 1.22886216 |
| 38 | UHMK1 | 1.22159996 |
| 39 | RET | 1.22032172 |
| 40 | DYRK1B | 1.20574741 |
| 41 | TRIB3 | 1.20107706 |
| 42 | SIK1 | 1.18894898 |
| 43 | MAPK13 | 1.17604490 |
| 44 | MAP3K11 | 1.16077334 |
| 45 | CDK15 | 1.14815130 |
| 46 | PAK6 | 1.13649162 |
| 47 | CDK18 | 1.13450990 |
| 48 | PHKG2 | 1.10589015 |
| 49 | PHKG1 | 1.10589015 |
| 50 | LATS2 | 1.10232961 |
| 51 | CDK14 | 1.10134304 |
| 52 | TSSK6 | 1.09912274 |
| 53 | CAMK2D | 1.09751093 |
| 54 | SIK2 | 1.07512972 |
| 55 | PRKCG | 1.06626283 |
| 56 | MUSK | 1.05868103 |
| 57 | MAP2K6 | 1.03076624 |
| 58 | CDK11A | 1.01720502 |
| 59 | CAMK2G | 1.00055721 |
| 60 | TNIK | 0.99119043 |
| 61 | MAPKAPK3 | 0.98847879 |
| 62 | FES | 0.98660132 |
| 63 | ADRBK1 | 0.97813479 |
| 64 | EEF2K | 0.95897334 |
| 65 | DAPK2 | 0.94212027 |
| 66 | TAOK1 | 0.92104338 |
| 67 | MARK2 | 0.92069250 |
| 68 | RIPK4 | 0.91398185 |
| 69 | PRKAA1 | 0.91045326 |
| 70 | TAOK2 | 0.89459047 |
| 71 | GRK6 | 0.87268072 |
| 72 | SCYL2 | 0.86494875 |
| 73 | STK39 | 0.84467006 |
| 74 | CAMK1G | 0.84015655 |
| 75 | ICK | 0.81914372 |
| 76 | CAMKK2 | 0.78899671 |
| 77 | KSR1 | 0.78108412 |
| 78 | WNK4 | 0.77791662 |
| 79 | CDK19 | 0.77695214 |
| 80 | PAK3 | 0.77216877 |
| 81 | TNK2 | 0.75852106 |
| 82 | EPHB1 | 0.75520263 |
| 83 | EPHA3 | 0.71683439 |
| 84 | LMTK2 | 0.71055071 |
| 85 | OXSR1 | 0.70686261 |
| 86 | FGR | 0.70500826 |
| 87 | PKN1 | 0.69576357 |
| 88 | CAMK4 | 0.68800088 |
| 89 | CAMKK1 | 0.67562818 |
| 90 | TESK1 | 0.64876888 |
| 91 | CCNB1 | 0.63652508 |
| 92 | AKT2 | 0.63633784 |
| 93 | PTK2B | 0.63444607 |
| 94 | RAF1 | 0.61467478 |
| 95 | MAPK4 | 0.61390180 |
| 96 | MAP2K1 | 0.60972701 |
| 97 | PRKCE | 0.59737215 |
| 98 | MAP3K1 | 0.59712303 |
| 99 | STK11 | 0.59384784 |
| 100 | MOS | 0.59175180 |
| 101 | BRAF | 0.57602694 |
| 102 | PTK2 | 0.57300293 |
| 103 | PRKAA2 | 0.56967019 |
| 104 | FER | 0.56224498 |
| 105 | SGK3 | 0.55302000 |
| 106 | CAMK1 | 0.54687710 |
| 107 | BCKDK | 0.52878837 |
| 108 | DAPK1 | 0.52820594 |
| 109 | MAP3K2 | 0.52301206 |
| 110 | PDPK1 | 0.51950443 |
| 111 | DMPK | 0.50682696 |
| 112 | SGK494 | 0.50183331 |
| 113 | SGK223 | 0.50183331 |
| 114 | WNK1 | 0.49319430 |
| 115 | ROCK2 | 0.49119354 |
| 116 | DYRK1A | 0.47715062 |
| 117 | PRKACA | 0.47129887 |
| 118 | DYRK2 | 0.46105575 |
| 119 | MATK | 0.43987707 |
| 120 | RPS6KA2 | 0.42444029 |
| 121 | CSNK1E | 0.40885002 |
| 122 | TYRO3 | 0.40637780 |
| 123 | PRKCH | 0.40010945 |
| 124 | TBK1 | 0.39428015 |
| 125 | PRKG1 | 0.38172595 |
| 126 | MAP3K6 | 0.37896560 |
| 127 | LIMK1 | 0.37872144 |
| 128 | SGK1 | 0.37409197 |
| 129 | RPS6KA3 | 0.37103982 |
| 130 | MAPK7 | 0.36755708 |
| 131 | BMPR1B | 0.36039807 |
| 132 | PRKCB | 0.35599186 |
| 133 | MYLK | 0.35437291 |
| 134 | PRKD3 | 0.35424879 |
| 135 | SGK2 | 0.35278978 |
| 136 | FYN | 0.34231811 |
| 137 | PIK3CA | 0.33703946 |
| 138 | ROCK1 | 0.33359361 |
| 139 | PDK1 | 0.32199189 |
| 140 | TRPM7 | 0.32179231 |
| 141 | CDC42BPA | 0.31344712 |
| 142 | DAPK3 | 0.31226947 |
| 143 | BMPR2 | 0.31129240 |
| 144 | MAPK11 | 0.30901941 |
| 145 | MAPK10 | 0.30769419 |
| 146 | PRKCA | 0.30392944 |
| 147 | ERBB3 | 0.30160885 |
| 148 | PRKG2 | 0.29662831 |
| 149 | PRKACG | 0.29338447 |
| 150 | MTOR | 0.28141829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.85573543 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73133717 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.39915757 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.38166327 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.14851109 |
| 6 | Cocaine addiction_Homo sapiens_hsa05030 | 3.06038697 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.83583534 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.72060354 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.49736369 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.40722128 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.38707983 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.29111591 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27163330 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.19910193 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10301875 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.04247747 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02521643 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 2.02135581 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.98932019 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.93846727 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92569397 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.90404246 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.86701772 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.85276049 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.80835505 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.79600967 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77257785 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.76845727 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.73455565 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.71850579 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67925200 |
| 32 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.66358048 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.60519789 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.57952007 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48799860 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.47882529 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47326251 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.44467151 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42600324 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.39500969 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35475717 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.33634285 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30987151 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27161293 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26764954 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26512358 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.26230462 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22956563 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22778072 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.22338821 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17227558 |
| 52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.16955095 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08962633 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 1.02264896 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01231164 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99218689 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95644162 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95273775 |
| 59 | Alcoholism_Homo sapiens_hsa05034 | 0.93438305 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89477764 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84716501 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84300140 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83902299 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.77677731 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77302282 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75976802 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.75773405 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75744037 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74029020 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72412348 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71910690 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71365488 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.71355720 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70328236 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69199161 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69062331 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68983442 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68261140 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66300130 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65127693 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.62195883 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61470088 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60221071 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59504817 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55890908 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54916910 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54102843 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52583285 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52343787 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52183355 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51822779 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51597009 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.51172931 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50893026 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50849932 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49623333 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48963865 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47553545 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.47325025 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46216452 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44549213 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44381673 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43262817 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41898540 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40711216 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39621318 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39434633 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39205176 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.37913992 |
| 110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.37000803 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.36792791 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35481890 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35274527 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34927865 |
| 115 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.31687830 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26650649 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26343785 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24365038 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23939475 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23857497 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22489894 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21476288 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20446558 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20178882 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20159974 |
| 126 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19555988 |
| 127 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19243413 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19145714 |
| 129 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17744508 |
| 130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16908195 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15473247 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.15293816 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.13641231 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.12616282 |
| 135 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11397524 |

